Skip to main content
. 2013 Sep 20;24(1):17–25. doi: 10.1093/glycob/cwt083

Table V.

Reinterpreted glycan array data for mAb JAA-F11 highlighting predicted false-negatives

ID Array glycan Experimental bindinga
1 Galβ1-3GalNAcα-Sp8 Yes
2 Galβ1-3GalNAcα-Sp16 Nod
3 Galβ1-3GalNAcα-Sp14 Nod
4 Neu5Acα2-6(Galβ1-3)GalNAcα-Sp8 Yes
5 Neu5Acα2-6(Galβ1-3)GalNAcα-Sp14 Nod
6 GlcNAcβ1-6(Galβ1-3)GalNAcα-Sp8 Yes
7 GlcNAcβ1-6(Galβ1-3)GalNAcα-Sp14 Nod
8 Galβ1-4GlcNAcβ1-6(Galβ1-3)GalNAcα-Sp8 Yes
9 Galβ1-4GlcNAcβ1-6(Galβ1-3)GalNAcα-Sp14 Nod
10 Neu5Acβ2-6(Galβ1-3)GalNAcα-Sp8 Yes
11 KDNα2-3Galβ1-3GalNAcα-Sp14 No
12 Neu5Acα2-6(Neu5Acα2-3Galβ1-3)GalNAcα-Sp14 No
13 Neu5Acα2-3Galβ1-4GlcNAcβ1-6(Neu5Acα2-3Galβ1-3)GalNAcα-Sp14 No
14 Neu5Acα2-3Galβ1-4(Fucα1-3)GlcNAcβ1-6(Galβ1-3)GalNAcα-Sp14 Nod
15 Fucα1-2Galβ1-3GalNAcα1-3(Fucα1-2)Galβ1-4Glcβ-Sp0 No
16 GlcNAcβ1-2Galβ1-3GalNAcα-Sp8 No
17 Neu5Acα2-3Galβ1-3GalNAcα-Sp8 No
18 Fucα1-2Galβ1-3GalNAcα-Sp14 No
19 Neu5Acα2-3Galβ1-3GalNAcα-Sp14 No
20 Neu5Acα2-6(Neu5Acα2-3Galβ1-3)GalNAcα-Sp8 No
21 Neu5Acα2-3Galβ1-4GlcNAcβ1-6(Galβ1-3)GalNAcα-Sp14 Nod
22 (3S)Galβ1-3GalNAcα-Sp8 No
23 Fucα1-2Galβ1-3GalNAcα-Sp8 No
24 Neu5Acα2-3Galβ1-4(Fucα1-3)GlcNAcβ1-6(Neu5Acα2-3Galβ1-3)GalNAcb-Sp14 No
25 Fucα1-2Galβ1-3GalNAcα1-3(Fucα1-2)Galβ1-4GlcNAcβ-Sp0 No
26 GalNAcα1-3(Fucα1-2)Galβ1-3GalNAcα1-3(Fucα1-2)Galβ1-4GlcNAcβ-Sp0 No
27 GlcNAcβ1-3Galβ1-3GalNAcα-Sp8 No
28 Galβ1-3GalNAcα1-3(Fucα1-2)Galβ1-4Glcc-Sp0 No
29 GlcNAcα1-4Galβ1-3GalNAcb-Sp14 No
30 Galβ1-3GalNAcα1-3(Fucα1-2)Galβ1-4GlcNAcc-Sp0 No
31 6S(Neu5Acα2-3Galβ1-3)GalNAcα-Sp8 No

aBinders defined as having greater than 10% of maximal RFUs at each protein concentrations (0.1, 5 and 200 μg/mL).

bReducing anomeric configuration undefined on the CFG array, α-configuration assumed for the CCG analysis.

cReducing anomeric configuration undefined on the CFG array, both configurations tested in the CCG analysis.

dHighlighted in grey are the predicted false negatives from the v4.0 CFG array screening of JAA-F11.